Literature DB >> 26892843

Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome.

Archana Hinduja1, Kenneth Habetz2, Sunil Raina3, Raghu Ramakrishnaiah4, Ryan T Fitzgerald4.   

Abstract

PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is an acute neurotoxic syndrome that, although characteristically reversible, can be fatal or result in long-term disability in a subset of patients. Our aim was to identify factors associated with poor discharge outcome in PRES patients.
MATERIALS AND METHODS: We retrospectively reviewed the clinical and radiological records of all patients with PRES admitted at our tertiary care medical center from 2007 to 2014. They were divided based their modified Rankin Score at discharge and compared for their baseline variables, clinical, laboratory and imaging features. Poor outcome was defined by a modified Rankin scale 2-6 and was subdivided based on the primary mechanism that led to poor outcome.
RESULTS: Out of 100 PRES subjects, 36% had poor discharge outcomes. Factors associated with poor outcomes on univariate analysis were history of diabetes mellitus, coma, high Charlson comorbidity index, post-transplantation, autoimmune condition, lack of systolic or diastolic hypertension, elevated blood urea nitrogen and involvement of the corpus callosum. On multivariate analysis, only prior diabetes mellitus odd ratio (OR) = 6.8 (95% CI 1.1-42.1, p = 0.04), corpus callosum involvement (OR = 11.7; 95% CI 2.4-57.4, p = 0.00) were associated with poor outcome. Poor outcome also correlated with increased length of hospital stay (OR = 7.9; 95% CI 1.3-49.7, p = 0.03).
CONCLUSION: Large prospective studies incorporating serial blood glucose values and advanced imaging studies are required to validate these findings.

Entities:  

Keywords:  PRES; hypertensive encephalopathy; poor outcome; posterior reversible encephalopathy syndrome

Mesh:

Year:  2016        PMID: 26892843     DOI: 10.3109/00207454.2016.1152966

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  10 in total

1.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.

Authors:  Andrew D Schweitzer; Neal S Parikh; Gulce Askin; Ajay Nemade; John Lyo; Sasan Karimi; Anna Knobel; Babak B Navi; Robert J Young; Ajay Gupta
Journal:  Neuroradiology       Date:  2017-03-13       Impact factor: 2.804

2.  Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study.

Authors:  Eberhard Siebert; G Bohner; T Liebig; M Endres; T G Liman
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

3.  Study of Clinicoradiological Profile in Posterior Reversible Encephalopathy Syndrome: An Experience from North India.

Authors:  Gourav Goyal; Jitesh Jeswani
Journal:  Indian J Crit Care Med       Date:  2022

4.  Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study.

Authors:  Hwazen Shash; Saad Aldaama; Hala Omer; Sameera Alafghani
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

5.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05

6.  An unusual presentation of a rare disease: posterior reversible encephalopathy syndrome following abdominal sepsis.

Authors:  Carly R N Richards; Robert C McMurray; Erik T Criman; Margaret E Clark; Suzanne Gillern
Journal:  J Surg Case Rep       Date:  2016-11-24

Review 7.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

Review 8.  Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging.

Authors:  Redmond-Craig Anderson; Vishal Patel; Nasim Sheikh-Bahaei; Chia Shang J Liu; Anandh G Rajamohan; Mark S Shiroishi; Paul E Kim; John L Go; Alexander Lerner; Jay Acharya
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

9.  Identification and Management of Posterior Reversible Encephalopathy Syndrome in a Patient Enrolled in an Immunotherapy Combination Phase I Clinical Trial: A Case Study.

Authors:  Fedricker D Barber
Journal:  Asia Pac J Oncol Nurs       Date:  2020-11-21

10.  The first two cases of posterior reversible encephalopathy syndrome (PRES) secondary to conventional transcatheter arterial chemoembolization of hepatocellular carcinoma.

Authors:  Kefeng Jia; Weili Yin; Fang Wang; Zhongsong Gao; Cheng Sun; Hui Wang; Yujuan Han; Yongmei Wang; Mingge Li; Changlu Yu
Journal:  BMC Gastroenterol       Date:  2021-12-20       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.